Fed­er­al judge rules against Mod­er­na in vac­cine IP suit

A fed­er­al judge ruled against Mod­er­na in a case al­leg­ing that the vac­cine mak­er in­fringed on Al­ny­lam’s patent for biodegrad­able lipids, which are used in Mod­er­na’s Covid-19 vac­cine.

Mod­er­na had ar­gued that Al­ny­lam’s claims need to be tak­en up against the fed­er­al gov­ern­ment, which was the sole pur­chas­er of the com­pa­ny’s vac­cine in the US.

Delaware dis­trict court judge Colm Con­nol­ly on Wednes­day ruled against Mod­er­na’s par­tial mo­tion, which sought to dis­miss claims from Al­ny­lam, the plain­tiff in this law­suit, re­gard­ing Mod­er­na’s sales of its Covid-19 vac­cine to the US gov­ern­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER